Global research trends in immunotherapy for head and neck neoplasms: A scientometric study

被引:4
作者
Jiang, Zhou [1 ]
Wu, Chenzhou [1 ]
Zhao, Yiming [1 ]
Zhan, Qi [1 ]
Wang, Kunyu [1 ]
Li, Yi [1 ,2 ]
机构
[1] Sichuan Univ, West China Hosp Stomatol, Natl Clin Res Ctr Oral Dis, Dept Head & Neck Oncol,State Key Lab Oral Dis, Chengdu 610041, Sichuan, Peoples R China
[2] Sichuan Univ, West China Hosp Stomatol, Dept Head & Neck Oncol, 14,3rd Sect Renminnan Ave, Chengdu 610041, Sichuan, Peoples R China
基金
中国国家自然科学基金;
关键词
Scientometric; Immunotherapy; Head and neck neoplasms; Head and neck squamous cell carcinoma; Nivolumab; PD-1; SQUAMOUS-CELL CARCINOMA; RADIOTHERAPY; RECURRENT; CANCER; COCITATION; NIVOLUMAB; ANTIBODY; IMMUNITY; SCIENCE; SAFETY;
D O I
10.1016/j.heliyon.2023.e15309
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
In recent decades, the traditional treatment of head and neck neoplasms has reached a bottleneck with limited improvement in overall survival. Nevertheless, the emerging field of immunotherapy has shown promise. Literature on research into immunotherapy for head and neck neoplasms was retrieved from WoSCC. Citespace was used as a scientometric analysis tool for text mining and visualization of the scientific literature. This analysis included 1915 documents. Recently, the annual number of publications and citations has been growing rapidly. 'Oncology' was the most popular research area. The most dominant institution and country were the University of Pitts-burgh and the USA. Ferris RL was not only the most prolific but also the most cited author, demonstrating a strong influence and reputation. Of the ten core journals identified in this field, Cancer Research ranked first. 'Regulatory T cell', 'PD-1' and 'biomarker' were regarded as current hotspots, while 'recurrent' and 'nivolumab' were considered as trending keywords. The most cited reference was Ferris RL (2016). Notably, the front trends and future directions in the field may lie in the clinical practice of combination therapy of immunotherapy plus other therapies, the mechanism of impaired immune surveillance, and the improvement in resistance to immu-notherapeutic agents. It is firmly believed that the present scientometric analysis has provided both a macroscopic and microscopic overview of research into immunotherapy for head and neck neoplasms, which will assist researchers and oncologists to better understand this discipline and thus promote further development and policies in this field.
引用
收藏
页数:10
相关论文
共 59 条
[31]   Tumor Antigen-Targeted, Monoclonal Antibody-Based Immunotherapy: Clinical Response, Cellular Immunity, and Immunoescape [J].
Ferris, Robert L. ;
Jaffee, Elizabeth M. ;
Ferrone, Soldano .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (28) :4390-4399
[32]   Immunotherapy improves efficacy and safety of patients with HPV positive and negative head and neck cancer: A systematic review and meta-analysis [J].
Galvis, Marisol Miranda ;
Borges, Gabriel Alvares ;
de Oliveira, Thiago Bueno ;
de Toledo, Isabela Porto ;
Castilho, Rogerio Moraes ;
Silva Guerra, Eliete Neves ;
Kowalski, Luiz Paulo ;
Squarize, Cristiane Helena .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2020, 150
[33]   Racial and socioeconomic disparities associated with 90-day mortality among patients with head and neck cancer in the United States [J].
Gaubatz, Matthew E. ;
Bukatko, Aleksandr R. ;
Simpson, Matthew C. ;
Polednik, Katherine M. ;
Boakye, Eric Adjei ;
Varvares, Mark A. ;
Osazuwa-Peters, Nosayaba .
ORAL ONCOLOGY, 2019, 89 :95-101
[34]   Biomarkers for immunotherapy response in head and neck cancer [J].
Gavrielatou, Niki ;
Doumas, Stergios ;
Economopoulou, Panagiota ;
Foukas, Periklis G. ;
Psyrri, Amanda .
CANCER TREATMENT REVIEWS, 2020, 84
[35]   Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial [J].
Gillison, Maura L. ;
Trotti, Andy M. ;
Harris, Jonathan ;
Eisbruch, Avraham ;
Harari, Paul M. ;
Adelstein, David J. ;
Sturgis, Erich M. ;
Burtness, Barbara ;
Ridge, John A. ;
Ringash, Jolie ;
Galvin, James ;
Yao, Min ;
Koyfman, Shlomo A. ;
Blakaj, Dukagjin M. ;
Razaq, Mohammed A. ;
Colevas, A. Dimitrios ;
Beitler, Jonathan J. ;
Jones, Christopher U. ;
Dunlap, Neal E. ;
Seaward, Samantha A. ;
Spencer, Sharon ;
Galloway, Thomas J. ;
Phan, Jack ;
Dignam, James J. ;
Quynh Thu Le .
LANCET, 2019, 393 (10166) :40-50
[36]   Carotid stenosis after adjuvant cervical radiotherapy in patients with head and neck cancers: a prospective controlled study [J].
Greco, A. ;
Gallo, A. ;
De Virgilio, A. ;
Marinelli, C. ;
Macri, G. F. ;
Fusconi, M. ;
Pagliuca, G. ;
de Vincentiis, M. .
CLINICAL OTOLARYNGOLOGY, 2012, 37 (05) :376-381
[37]   Early (90-day) mortality after radical radiotherapy for head and neck squamous cell carcinoma: A population-based analysis [J].
Hamilton, Sarah Nicole ;
Tran, Eric ;
Berthelet, Eric ;
Wu, Jonn ;
Olson, Robert .
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2018, 40 (11) :2432-2440
[38]   The molecular biology of head and neck cancer [J].
Leemans, C. Rene ;
Braakhuis, Boudewijn J. M. ;
Brakenhoff, Ruud H. .
NATURE REVIEWS CANCER, 2011, 11 (01) :9-22
[39]   Immunotherapy for head and neck squamous cell carcinoma [J].
Li, Qiao ;
Prince, Mark E. P. ;
Moyer, Jeffrey S. .
ORAL ONCOLOGY, 2015, 51 (04) :299-304
[40]   Evidence for a Role of the PD-1:PD-L1 Pathway in Immune Resistance of HPV-Associated Head and Neck Squamous Cell Carcinoma [J].
Lyford-Pike, Sofia ;
Peng, Shiwen ;
Young, Geoffrey D. ;
Taube, Janis M. ;
Westra, William H. ;
Akpeng, Belinda ;
Bruno, Tullia C. ;
Richmon, Jeremy D. ;
Wang, Hao ;
Bishop, Justin A. ;
Chen, Lieping ;
Drake, Charles G. ;
Topalian, Suzanne L. ;
Pardoll, Drew M. ;
Pai, Sara I. .
CANCER RESEARCH, 2013, 73 (06) :1733-1741